Cart
sales@molnova.com
9-CP-Ade Mesylate
CAS No. 189639-09-6
9-CP-Ade Mesylate( —— )
Catalog No. M33955 CAS No. 189639-09-6
9-CP-Ade Mesylate (9 CP Ade Mesylate) is a cell-permeable, stable and non-competitive inhibitor of adenylate cyclase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 93 | Get Quote |
|
| 5MG | 140 | Get Quote |
|
| 10MG | 217 | Get Quote |
|
| 25MG | 385 | Get Quote |
|
| 50MG | 569 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name9-CP-Ade Mesylate
-
NoteResearch use only, not for human use.
-
Brief Description9-CP-Ade Mesylate (9 CP Ade Mesylate) is a cell-permeable, stable and non-competitive inhibitor of adenylate cyclase.
-
Description9-Cyclopentyladenine monomethylsulfonate (9-CP-Ade mesylate) is a stable non-competitive adenylate cyclase inhibitor with cell permeable properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number189639-09-6
-
Formula Weight299.35
-
Molecular FormulaC11H17N5O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 41.67 mg/mL (139.20 mM; Ultrasonic (<60°C)
-
SMILESCS(O)(=O)=O.Nc1ncnc2n(cnc12)C1CCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ulrike Riese，et al. Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways. FEBS Lett. 2004 Nov 19;577(3):455-9.?
molnova catalog
related products
-
Pimethixene maleate
Pimethixene maleate (Pimetixene maleate) is a potent 5-HT2B receptor antagonist with sedative and antitussive activity.
-
BuChE-IN-TM-10
BuChE-IN-TM-10 (TM-10) is a potent inhibitor of butyrylcholinesterase (BuChE) with an IC50 of 8.9 nM.
-
DMAB-anabaseine dihy...
DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
